Endometriosis and the Silent Heart Risk: A Systematic Review of Cardiovascular Disease in Affected Women

In: Journal of Medical and Health Studies · 2026 · vol. 7(1) , pp. 01–09 · doi:10.32996/jmhs.2026.7.1.1 · W7118071508
Systematic review / meta-analysis OA: diamond CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-12 ⓘ

This systematic review finds that endometriosis is associated with a modest but consistent increase in cardiovascular disease risk, including higher rates of ischemic heart disease and hypertension among affected women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-12 · read from full text ⓘ

This systematic review evaluated the association between endometriosis and various cardiovascular disease outcomes by analyzing observational studies and meta-analyses published between 2000 and 2025. The analysis of large cohorts involving over 1.4 million women revealed that endometriosis is linked to a modest but consistent increase in risk for conditions such as ischemic heart disease, stroke, hypertension, and arrhythmias. Researchers noted elevated hazard ratios for coronary artery disease and evidence of impaired endothelial function, indicating subclinical atherosclerosis in affected patients. This paper is centrally about endometriosis — specifically investigating its role as a systemic inflammatory condition that contributes to increased cardiovascular risk in reproductive-aged women.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis affects approximately 10% of reproductive-aged women worldwide and is increasingly recognized as a chronic systemic inflammatory condition that may contribute to cardiovascular disease (CVD). We conducted a PRISMA 2020–guided systematic review to evaluate the association between endometriosis and cardiovascular outcomes. We searched PubMed (Medline), Embase, Scopus, and Web of Science for observational studies and meta-analyses published between January 2000 and May 2025, with emphasis on evidence from 2019–2025. Eligible studies compared cardiovascular outcomes in women with clinically or surgically diagnosed endometriosis versus women without endometriosis. Outcomes included myocardial infarction, ischemic heart disease, stroke, hypertension, arrhythmias, heart failure, atherosclerotic markers, and venous thromboembolism. Two reviewers independently screened records, extracted data, and assessed study quality following PRISMA guidance. Large cohort studies and recent meta-analyses consistently demonstrate higher cardiovascular risk among women with endometriosis. Adjusted hazard ratios reported in primary studies ranged from 1.12 for new-onset hypertension to 1.52 for coronary artery disease. Meta-analyses including over 1.4 million women reported pooled hazard ratios of ~1.35 for ischemic heart disease and ~1.19 for cerebrovascular disease. Subclinical studies show impaired endothelial function and increased markers of early atherosclerosis in women with endometriosis. Endometriosis is associated with a modest but consistent increase in risk of several cardiovascular outcomes across diverse populations and study designs. These findings support systematic cardiovascular risk assessment and appropriate preventive strategies in women with endometriosis.
Full text 1,928 characters · extracted from oa-doi-fallback · click to expand
Article contents Endometriosis and the Silent Heart Risk: A Systematic Review of Cardiovascular Disease in Affected Women Abstract Endometriosis affects approximately 10% of reproductive-aged women worldwide and is increasingly recognized as a chronic systemic inflammatory condition that may contribute to cardiovascular disease (CVD). We conducted a PRISMA 2020–guided systematic review to evaluate the association between endometriosis and cardiovascular outcomes. We searched PubMed (Medline), Embase, Scopus, and Web of Science for observational studies and meta-analyses published between January 2000 and May 2025, with emphasis on evidence from 2019–2025. Eligible studies compared cardiovascular outcomes in women with clinically or surgically diagnosed endometriosis versus women without endometriosis. Outcomes included myocardial infarction, ischemic heart disease, stroke, hypertension, arrhythmias, heart failure, atherosclerotic markers, and venous thromboembolism. Two reviewers independently screened records, extracted data, and assessed study quality following PRISMA guidance. Large cohort studies and recent meta-analyses consistently demonstrate higher cardiovascular risk among women with endometriosis. Adjusted hazard ratios reported in primary studies ranged from 1.12 for new-onset hypertension to 1.52 for coronary artery disease. Meta-analyses including over 1.4 million women reported pooled hazard ratios of ~1.35 for ischemic heart disease and ~1.19 for cerebrovascular disease. Subclinical studies show impaired endothelial function and increased markers of early atherosclerosis in women with endometriosis. Endometriosis is associated with a modest but consistent increase in risk of several cardiovascular outcomes across diverse populations and study designs. These findings support systematic cardiovascular risk assessment and appropriate preventive strategies in women with endometriosis.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK